• Other Medical Research N.E.C.

• 262.

Human Growth Foundation

Our vision is that everyone with a rare growth, bone, and endocrine condition can access the best care possible.

• Alliance/Advocacy Organizations

• 263.

Colon Cancer Alliance for Research and Education for Lynch Syndrome

The non-profit dedicated to Lynch Syndrome education & awareness, the # 1 hereditary cause of uterine & colon cancers.

Society for Leukocyte Biology

SLB promotes research and encourages young investigators to improve current understanding of the importance of leukocyte biology in disease.

Martin Center, Inc.

Martin Center Sickle Cell Initiative’s mission is to aid and enhance the lives of those affected by Sickle Cell and associated disorders by providing client services, patient and family advocacy, and education.

• Birth Defects, Genetic Diseases

• 266.

International Rett Syndrome Association, Inc.

We are transforming lives every day in our fight to treat and cure Rett syndrome and better the lives of families living with this devastating disorder.

• Private Grantmaking Foundations

• 267.

Wallace Beeson Foundation Inc

A 501(c) founded in 2017 to raise money for research in rare Neurogastrointestinal & Motility Disease Home About Research Our Team More JOIN OUR FIGHT TOMAKE RARE KNOWN Funding Research for Rare Neurogastrointestinal Motility disorders YOUR DONATION FUNDS A DESPERATE NEED IN RESEARCH HOW WE STARTED From being a healthy 15yearold competitive swimmer to having to fight for herlife almost overnight Wallacesaw first hand the effect a rare condition has on someone.

Hunters CMT4B3 Research Foundation Inc

Pioneering cutting edge scientific research to develop treatments for CMT4B3 patients and children with rare neuromuscular diseases.

• Arthritis

• 269.

Arthritis Foundation

Here for the 1 in 4 with #arthritis. | Fighting to cure the #1 cause of disability.

• Alliance/Advocacy Organizations

• 270.

Arthritis Foundation

Here for the 1 in 4 with #arthritis. | Fighting to cure the #1 cause of disability.